Skip to main content
. 2023 Feb 22;11(2):e00960-22. doi: 10.1128/spectrum.00960-22

TABLE 3.

Haplotype frequencies in ART and partner drug resistance-associated genes observed in at least 1 sampleb

Drug(s) and gene haplotype(s) 2003–2005
2008–2012
2014–2018
χ2 P value
No. of samples with haplotype/total no. of samples % of samples with haplotype (95% CI) No. of samples with haplotype/total no. of samples % of samples with haplotype (95% CI) No. of samples with haplotype/total no. of samples % of samples with haplotype (95% CI)
ART
K13
  G449Ca 1/141 0.7 (0.1–4.9) 0/68 0 1/45 2.2 (0.3–73.4) 0.03621
  K189T 94/141 66.7 (58.4–74.0) 42/68 61.8 (49.6–73.6) 25/45 55.6 (40.7–73.4)
  wt 15/141 10.6 (6.5–17.0) 16/68 23.5 (14.9–73.6) 3/45 6.7 (2.1–73.4)
  wt incomplete 29/141 20.6 (14.6–28.1) 10/68 14.7 (8.0–73.6) 14/45 31.1 (19.2–73.4)
  Missing 2/141 1.4 (0.4–5.6) 0/68 0 2/45 4.4 (1.1–73.4)
ubp1
  Q107L and/or K1193T type 60/141 42.6 (34.6–50.9) 6/68 8.8 (4.0–18.4) 3/45 6.7 (2.1–19.0) <2.2e−16
  R1133S type 21/141 14.9 (9.9–21.8) 7/68 10.3 (4.9–20.2) 1/45 2.2 (0.3–14.6)
  R1133S + E1011K type 33/141 23.4 (17.1–31.2) 53/68 77.9 (66.4–86.3) 41/45 91.1 (78.3–96.7)
  Polyclonal Q107L/K1193T+ R1133S 3/141 2.1 (0.7–6.4) 1/68 1.5 (0.2–9.9) 0/45 0
  wt or wt incomplete 24/141 17.0 (11.6–24.2) 1/68 1.5 (0.2–9.9) 0/45 0
coronin
  V424I 78/141 55.3 (47.0–63.4) 41/68 60.3 (48.2–71.3) 37/45 82.2 (68.0–91.0) 0.002743
  V62M 29/141 20.6 (14.6–28.1) 5/68 7.4 (3.1–16.6) 0/45 0
  wt 30/141 21.3 (15.3–28.9) 20/68 29.4 (19.7–41.4) 8/45 17.8 (9.0–32.0)
  Polyclonal 0/141 0 1/68 1.5 (0.2–9.9) 0/45 0
  Incomplete 4/141 2.8 (1.1–7.4) 1/68 1.5 (0.2–9.9) 0/45 0
SP
dhfr
  Single mutant (S108N) 98/141 69.5 (61.4–76.6) 6/68 8.8 (4.0–18.4) 0/45 0 <2.2e−16
  Double mutant + BR + I164L 32/141 22.7 (16.5–30.4) 0/68 0 0/45 0
  Triple mutant 0/141 0 61/68 89.7 (79.8–95.1) 44/45 97.8 (85.4–99.7)
  Incomplete 3/141 2.1 (0.7–6.4) 0/68 0 1/45 2.2 (0.3–14.6)
  Missing 6/141 4.3 (1.9–9.2) 1/68 1.5 (0.2–9.9) 0/45 0
dhps
  Single mutant K540K 16/141 11.3 (7.0–17.8) 0/68 0 0/45 0 <2.2e−16
  Single mutant A437G 3/141 2.1 (0.7–6.4) 1/68 1.5 (0.2–9.9) 0/45 0
  Double mutant 14/141 9.9 (5.9–16.1) 0/68 0 0/45 0
  Triple mutant 2/141 1.4 (0.4–5.6) 48/68 70.6 (58.6–80.3) 30/45 66.7 (51.6–79.0)
  Incomplete mutant 7/141 5.0 (2.4–10.1) 13/68 19.1 (11.4–30.4) 12/45 26.7 (15.7–41.6)
  wt 80/141 56.7 (48.4–64.7) 4/68 5.9 (2.2–14.8) 2/45 4.4 (1.1–16.4)
  wt incomplete 19/141 13.5 (8.7–20.2) 2/68 2.9 (0.7–11.2) 1/45 2.2 (0.3–14.6)
CQ and MQ
crt (positions 72–76)
  CVMNT 65/141 46.1 (38.0–54.4) 2/68 2.9 (0.7–11.2) 0/45 0 8.37e−16
  SVMNT 49/141 34.8 (27.3–43.0) 60/68 88.2 (78.0–94.1) 32/45 71.1 (56.1–82.6)
  CVMNT/SVMNT polyclonal 0/141 0 1/68 1.5 (0.2–9.9) 0/45 0
  Incomplete 27/141 19.1 (13.4–26.6) 5/68 7.4 (3.1–16.6) 13/45 28.9 (17.4 to 43.9)
mdr1 (positions 86, 144, 184, 1034, 1042, 1246)
  NDFCDD 61/141 43.3 (35.3–51.6) 1/68 1.5 (0.2–9.9) 0/45 0 <2.2e−16
  ND_CDD 2/141 1.4 (0.4–5.6) 0/68 0 0/45 0
  NDFCDY 17/141 12.1 (7.6–18.6) 60/68 88.2 (78.0–94.1) 42/45 93.3 (81.0–97.9)
  NGFSDD 43/141 30.5 (23.4–38.6) 5/68 7.4 (3.1–16.6) 0/45 0
  NG_SDD 4/141 2.8 (1.1–7.4) 0/68 0 0/45 0
  NDFSDD 1/141 0.7 (0.1–4.9) 0/68 0 0/45 0
  Polyclonal 5/141 3.5 (1.5–8.3) 0/68 0 0/45 0
  Incomplete 8/141 5.7 (2.8–11.0) 2/68 2.9 (0.7–11.2) 3/45 6.7 (2.1–19.0)
a

One out of 2 samples with G449C was also accompanied by K189T; both cases were polyclonal infections.

b

Note that the ubp1 haplotype with R1133S and E1011K was frequently observed with additional SNP mutations (K764N, K774N, and D777G) and a large insert (EQKY) between amino acid positions 2826 and 2827. dhps double mutant indicates the A437G A581G mutant; dhps triple mutant indicates the A437G A581G K540E mutant. wt, wild type; CI, confidence interval.